General MedicationsTOPICALStandard
REGRANEX
BECAPLERMIN
Standard Dose
100UG/G
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview REGRANEX is listed in Drugs@FDA under application 103691 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient BECAPLERMIN Form and strength GEL; TOPICAL - 100UG/G Sponsor SMITH AND NEPHEW Submission history Latest submission status date: 2019-08-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview REGRANEX is listed in Drugs@FDA under application 103691 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient BECAPLERMIN Form and strength GEL; TOPICAL - 100UG/G Sponsor SMITH AND NEPHEW Submission history Latest submission status date: 2019-08-26 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.